InfuSystem Holdings, Inc
About InfuSystem Holdings, Inc
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $143.4M
- Net income
- $6.6M
- Total assets
- $100.6M
- Market cap
- $186.5M
- Gross margin
- 56.0%
- Operating margin
- 8.3%
- Net margin
- 4.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $143.4M
- Cost of revenue
- $63.1M
- Gross profit
- $80.3M
- Operating expenses
- $68.4M
- Operating income
- $11.9M
- Income tax
- $4.0M
- Net income
- $6.6M
- EPS (basic)
- $0.32
- EPS (diluted)
- $0.31
Balance sheet
- Total assets
- $100.6M
- Current assets
- $36.3M
- Total liabilities
- $43.2M
- Current liabilities
- $20.2M
- Shareholders’ equity
- $57.3M
Cash flow
- Operating cash flow
- $24.4M
- Investing cash flow
- -$6.8M
- Financing cash flow
- -$15.0M
- Net cash flow
- $2.7M
Statements via Polygon.io (SEC filings)
- Market cap
- $186.5M
- P/E ratio
- 29.1
- EPS (diluted)
- $0.31
- Shares outstanding
- 20.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 22, 1992
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $6.6M in FY2025.
- Revenue grew 40% from FY2021 to FY2025.
- Gross margin of 56.0%, net margin 4.6%.
- Trading 16% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 29.1.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review InfuSystem Holdings, Inc.
Write a review
News about InfuSystem Holdings, Inc
News & sentiment via Polygon.io
